MarketInOut Stock Screener Log In | Sign Up
 

IntegraGen S.A.

PAR • Healthcare • Biotechnology • Quote as of 10/12/2026 13:29
IntegraGen S.A. stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization0.339 mln
Float2.23 mln
Earnings Date04/29/2025

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-5.17
Highly reliable

Relative Strength

0 / 100
Severely lagging

Pre-Tax Margin

-55%
Severely loss-making

ROE

-676
Deeply negative

Altman Z-Score

-3.68
Deeply distressed

Business Description

IntegraGen SA is a French company that helps researchers study cancer and rare diseases by providing DNA sequencing, data analysis, and expert scientific support. The company offers several tools to make sense of complex genetic data, including an online platform that turns raw sequencing results into clear reports for medical research, and a cloud application for exploring gene expression data. Researchers can also access a consulting service that connects them with specialists in biostatistics and data analysis. Founded in 2000 and based in Évry, France, IntegraGen operates as part of the OncoDNA group.

Key Fundamentals

EPS-0.02
ROE-676
RPS0.76
ROIC-116
ROA-67.05
Interest Cover-1,511
EBITDA, mln-2.71
EV / EBITDA0.12
EV / EBIT0.12
Revenue, mln5.02

Quote Details

Last 0.019
Change -0.0084 (-30.66%)
Open 0.0204
Volume 44,540
Turnover 846.26
Average Volume 37,835

Financial Ratios

Pre-Tax Profit Margin-55
Current Ratio0.87
Price / Sales0.09

Financial Strength

Altman Z-Score-3.68
Piotroski F-Score 2 / 9
Beneish M-Score-5.17

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -71.89% 0 / 100   
1 Month -90.55% 0 / 100   
2 Months -88.01% 0 / 100   
6 Months -89.08% 1 / 100   
1 Year -87.16% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us